Gossamer Bio (GOSS) 10-Q2023 Q1 Quarterly report

Filed: 9 May 23, 4:02pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: accomplish, accretion, appointed, attract, attrition, blinded, Chairman, Chief, competition, death, decided, defense, description, difficult, difficulty, disability, diversion, earliest, epidemic, exhibit, expose, facilitate, Faheem, flat, foregoing, Gujrathi, Hasnain, headcount, iii, impede, implement, implementation, incentivize, incident, increasingly, intense, interstitial, iv, leadership, life, lung, managerial, member, middle, modification, morale, motivate, ordinary, overnight, Premium, President, proportionately, recruit, recruiting, replacement, replacing, Repriced, repricing, resale, retain, retained, retaining, returned, scientific, Sheila, SOFR, split, strategy, thereunder, turnover, unexpected, unique

Removed: Aadi, advance, Aerpio, al, alleged, allocation, amend, amortization, approving, authoritative, Bank, behalf, caption, captioned, charge, closed, closure, CNS, collection, complaint, contracted, converted, Court, customarily, deferred, delayed, denied, deprioritized, disclose, District, embedded, enrolling, enrollment, equitable, expanded, failed, false, FASB, favor, feature, fourth, globe, healthy, hearing, Hedging, impractical, indirect, individually, informed, Kuhne, lawsuit, leave, local, lymphoma, medical, misleading, modified, motion, moved, multiple, PCNSL, Pending, plaintiff, point, posed, preliminarily, prime, principle, prolonged, putative, rare, ratio, reached, refer, refractory, relapsed, relief, remeasured, retrospective, satisfaction, Scott, separated, Silicon, similarly, situated, sought, Southern, STAR, Subtopic, tax, temporarily, temporary, therapeutic, timeline, traceable, treating, undergoing, underway, unlawful, unspecified, updated, vacated, Valley, violation, work

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

GOSS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Bryan Giraudo, Chief Operating Officer and Chief Financial Officer of Gossamer Bio, Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

•the accompanying Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2023 (the “Report”), as filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

•the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

Date: May 9, 2023


/s/ Bryan Giraudo
Bryan Giraudo
Chief Operating Officer and Chief Financial Officer
(Principal Financial and Accounting Officer)